Actively Recruiting
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
Led by Diabetes Solutions International · Updated on 2025-04-25
40
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
Sponsors
D
Diabetes Solutions International
Lead Sponsor
D
DexCom, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care. The main questions it aims to answer are: Does use of CGM \& RPM improve A1c? Does use of CGM \& RPM improve the percent of time spent with glucose levels between 70-180 mg/dl? Does the diabetes care management program improve diabetes related distress? Participants enrolled in the study will be wearing a CGM. Participants will be able to see the glucose readings from the CGM and see how their glucose level responds to food, physical activity, medications and daily life. The diabetes primary care team will be remotely monitoring the participant's glucose data from the CGM. They will reach out to the participant to make adjustments in treatment regimen as needed. Participants will answer a "Problem Areas in Diabetes"questionnaire that asks questions about diabetes related distress.
CONDITIONS
Official Title
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older with Type 2 diabetes
- A1c > 8%
You will not qualify if you...
- Pregnancy (participant-reported)
- Previous real time CGM use for more than 6 weeks in the last 3 months
- Use of steroids
- Active cancer treatment
- Terminal illness
- Dementia, mental impairment
- Type 1 diabetes
- End stage renal disease, on dialysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Community Health Center of Franklin County
Greenfield, Massachusetts, United States, 01301
Actively Recruiting
Research Team
S
Sushma Reddy, MD
CONTACT
J
Jill Einstein, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here